Journal article
Pharmacokinetics and safety profile of artesunate-amodiaquine co-administered with antiretroviral therapy in malaria uninfected HIV-positive Malawian adults
- Abstract:
-
There are limited data on the pharmacokinetic and safety profiles of artesunate-amodiaquine in human immnunodeficiency virus infected (HIV+) individuals receiving antiretroviral therapy. In a two-step intensive sampling pharmacokinetic trial, we compared area under the concentration-time curve from 0 to 28 days (AUC0-28 days) of an active metabolite of amodiaquine, desethylamodiaquine, and treatment-emergent adverse events between antiretroviral therapy-naive HIV+ adults and those taking nevi...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
European and Developing Countries Clinical Trials Partnership
More from this funder
Bibliographic Details
- Publisher:
- American Society for Microbiology Publisher's website
- Journal:
- Antimicrobial Agents and Chemotherapy Journal website
- Volume:
- 62
- Issue:
- 7
- Pages:
- e00412-18
- Publication date:
- 2018-05-14
- Acceptance date:
- 2018-05-14
- DOI:
- EISSN:
-
1098-6596
- ISSN:
-
0066-4804
- Pmid:
-
29760133
- Source identifiers:
-
848004
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:848004
- UUID:
-
uuid:5a85901f-8213-49e2-9be6-0e6b01520a78
- Local pid:
- pubs:848004
- Deposit date:
- 2018-05-29
Terms of use
- Copyright holder:
- Banda et al
- Copyright date:
- 2018
- Notes:
- Copyright © 2018 Banda et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record